SCHEMBL10242673

SCHEMBL10242673

CC(=O)c1c(C)nc2ccc(C)cn12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.61
ALDH1A1 P00352 5/20 0.54
KDM4E B2RXH2 4/20 0.54
GAA P10253 2/20 0.54
HTT P42858 2/20 0.52
MAPT P10636 1/20 0.52
LMNA P02545 3/20 0.50
POLB P06746 1/20 0.49
RAB9A P51151 4/20 0.47
NPC1 O15118 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
COMT P21964 1/20 0.44
MAP3K14 Q99558 1/20 0.42
ALB P02768 1/20 0.42
CYP3A4 P08684 1/20 0.42
CHRM1 P11229 1/20 0.42
GABRA1 P14867 1/20 0.42
HPGD P15428 1/20 0.42
GABRB1 P18505 1/20 0.42
GABRG2 P18507 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2931119 0.86 ALDH1A1 (0.54) KMT2AALDH1A1KDM4EGAAHTT
SCHEMBL3283016 0.85 TGFBR1 (0.55) KMT2AALDH1A1KDM4EGAAHTT
SCHEMBL4256814 0.83 KMT2A (0.58) KMT2AALDH1A1KDM4EGAAHTT
SCHEMBL15445014 0.83 RAB9A (0.46) KMT2AALDH1A1KDM4EGAAHTT
SCHEMBL6112913 0.83 ALDH1A1 (0.69) KMT2AALDH1A1GAAPOLBRAB9A
SCHEMBL4794691 0.81 KMT2A (0.55) KMT2AALDH1A1KDM4EGAAHTT
SCHEMBL6012095 0.81 RAB9A (0.59) ALDH1A1KDM4EGAAMAPTLMNA
SCHEMBL10514161 0.81 ALDH1A1 (0.74) KMT2AALDH1A1KDM4EGAAHTT
SCHEMBL4531748 0.80 KMT2A (0.54) KMT2AALDH1A1KDM4EGAAPOLB
SCHEMBL13633334 0.80 RAB9A (0.68) KMT2AALDH1A1KDM4EGAAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9908876-B2 Imidazo [1,2-a]pyridine compounds, synthesis thereof, and methods of using same UNIVERSITY OF NOTRE DAME DU LAC (US) 2018-03-06 US disclosed
US-8148373-B2 Compounds ASTRAZENECA AB (SE) 2012-04-03 US disclosed
US-20090298807-A1 Compounds ASTRAZENECA AB (SE) 2009-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298807-A1 Compounds PKD1, SLC10A1, ABCB11 KMT2A 4286/4885ALDH1A1 102/4885KDM4E 3670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.